FDA to Cut Back Hiring of Non-US Citizens

The move appears to be out of step with other HHS agencies.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FDA building with signFDAHiring managers at the US Food and Drug Administration (FDA) will soon be unable to extend offers to non-citizens who have lived in the United States for fewer than three of the past five years, reports STAT. The policy, attributed to changes in the background check procedures needed to procure a government employee ID card, does not appear to be in line with policies at other federal science agencies, STAT finds.

A government policy on the ID cards, implemented in 2008, stipulates that applicants must have lived in the country for at least three of the preceding five years in order to complete the background check—but it also suggests that those who do not meet the requirement can be hired and use a different type of card until eligible.

An FDA document obtained by STAT states that the agency’s hiring change is due to a January 2017 update to that policy. Yet, “an HHS spokesman said the internal document did not include new policies on a residency requirement,” the outlet reports.

The order, expected to take effect October 1, will not apply to current employees. Nevertheless, two FDA staffers tell STAT they were “dismayed” and “stunned” ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Shawna Williams

    Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor's degree in biochemistry from Colorado College and a graduate certificate and science communication from the University of California, Santa Cruz.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo